• Event Times (GMT+1)
  • Local Times (GMT+2)
Data Blitz Session
Session Room: M4
Monday, June 29, 10:50 AM – 12:05 PM
Data Blitz 8:
Late Breakers 1: Mood, Anxiety, and Stress Related Disorders
A new pharmacological strategy against treatment-resistant depression.
10:50 AM – 10:56 AM
6 min
Synergistic Modulation of Monoamine Circuitry: A Novel Non-Benzodiazepine Anxiolytic Strategy
10:56 AM – 11:02 AM
6 min
Addressing Clinical Trial Heterogeneity in Neuropsychiatric Long COVID Research: A Registry-Based Cross-Sectional Analysis of Pharmacotherapeutic Intervention Trial Designs
11:02 AM – 11:08 AM
6 min
The Maudsley Advanced Treatment Service: Maudsley Ketamine Clinical Research Experience
11:08 AM – 11:14 AM
6 min
Polygenic liability to psychiatric disorders predicts depressive and anxiety symptoms across pregnancy and postpartum
11:14 AM – 11:20 AM
6 min
Atypical Symptoms Associated with Metabolic, But Not Inflammatory, Biomarkers in Bariatric Surgery Patients with Depression
11:20 AM – 11:26 AM
6 min
Tau Pathology Modulates the Association Between Neurodegeneration and Depressive Symptoms in Alzheimer’s Disease
11:26 AM – 11:32 AM
6 min
Classification of Major Depressive Disorder Subtypes via Surface-based Brain Imaging and Clinical Features
11:32 AM – 11:38 AM
6 min
A Retrospective Report of Efficacy and Tolerability of Low Daily Dose Ketamine for Depression and Anxiety in a Large Population Sample
11:38 AM – 11:44 AM
6 min
Computational modelling of cognitive flexibility reveals novel dissociations across compulsive and non-compulsive disorders
11:44 AM – 11:50 AM
6 min

Mapping the global biomarker landscape in anxiety, depression and psychosis: a global infrastructure and consensus initiative for precision psychiatry

11:50 AM – 11:56 AM
6 min
Moderated Discussion, Q&A
11:56 AM – 12:05 PM
9 min